(VIANEWS) – Palomar Holdings (PLMR), Huntington Bancshares (HBAN), Acadia Healthcare Company (ACHC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Palomar Holdings (PLMR)

42.4% sales growth and 7.4% return on equity

Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers.

Palomar Holdings’s sales growth this year is expected to be 48.4% and 37.6% for next year.

Year-on-year quarterly revenue growth grew by 50.4%, now sitting on 216.92M for the twelve trailing months.

Volume

Today’s last reported volume for Palomar Holdings is 200760 which is 23.25% above its average volume of 162886.

Palomar Holdings’s sales growth for the next quarter is 42.4%. The company’s growth estimates for the ongoing quarter and the next is 1400% and negative -5.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.4%.

Volatility

Palomar Holdings’s last day, last week, and last month’s current intraday variation average was 0.55%, 2.13%, and 2.70%, respectively.

Palomar Holdings’s highest amplitude of average volatility was 4.80% (day), 5.79% (last week), and 5.81% (last month), respectively.

Palomar Holdings’s Stock Yearly Top and Bottom Value

Palomar Holdings’s stock is valued at $53.14 at 00:22 EST, way under its 52-week high of $115.40 and way above its 52-week low of $44.01.

Palomar Holdings’s Moving Average

Palomar Holdings’s worth is way below its 50-day moving average of $61.79 and way under its 200-day moving average of $75.18.

2. Huntington Bancshares (HBAN)

37.6% sales growth and 6.92% return on equity

Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.

Huntington Bancshares’s sales growth this year is expected to be 24.8% and 13.1% for next year.

Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 4.69B for the twelve trailing months.

Volume

Today’s last reported volume for Huntington Bancshares is 10814000 which is 8.45% below its average volume of 11812400.

Huntington Bancshares’s sales growth is a negative 0% for the current quarter and 37.6% for the next. The company’s growth estimates for the ongoing quarter and the next is 22.2% and 25.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.92%.

Volatility

Huntington Bancshares’s last day, last week, and last month’s current intraday variation average was 0.82%, 1.07%, and 1.93%, respectively.

Huntington Bancshares’s highest amplitude of average volatility was 3.04% (day), 2.45% (last week), and 3.45% (last month), respectively.

Huntington Bancshares’s Stock Yearly Top and Bottom Value

Huntington Bancshares’s stock is valued at $15.92 at 00:22 EST, below its 52-week high of $16.91 and way above its 52-week low of $12.00.

Huntington Bancshares’s Moving Average

Huntington Bancshares’s worth is under its 50-day moving average of $15.93 and above its 200-day moving average of $15.34.

3. Acadia Healthcare Company (ACHC)

8% sales growth and 7.61% return on equity

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.

Acadia Healthcare Company’s sales growth this year is anticipated to be 10.4% and 7.4% for next year.

Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 2.26B for the twelve trailing months.

Volume

Today’s last reported volume for Acadia Healthcare Company is 58727 which is 85.8% below its average volume of 413579.

Acadia Healthcare Company’s sales growth for the next quarter is 8%. The company’s growth estimates for the current quarter and the next is a negative 39.8% and 36.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.61%.

Volatility

Acadia Healthcare Company’s last day, last week, and last month’s current intraday variation average was 2.15%, 1.73%, and 2.07%, respectively.

Acadia Healthcare Company’s highest amplitude of average volatility was 5.18% (day), 4.01% (last week), and 4.06% (last month), respectively.

Acadia Healthcare Company’s Stock Yearly Top and Bottom Value

Acadia Healthcare Company’s stock is valued at $53.00 at 00:22 EST, way under its 52-week high of $68.65 and above its 52-week low of $49.88.

Acadia Healthcare Company’s Moving Average

Acadia Healthcare Company’s worth is below its 50-day moving average of $56.26 and way below its 200-day moving average of $61.05.

4. Mettler (MTD)

7.9% sales growth and 257.07% return on equity

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services worldwide.

Mettler’s sales growth this year is expected to be 18.9% and 3.8% for next year.

Year-on-year quarterly revenue growth grew by 23.9%, now sitting on 3.24B for the twelve trailing months.

Volume

Today’s last reported volume for Mettler is 283812 which is 163.09% above its average volume of 107874.

Mettler’s sales growth for the next quarter is 7.9%. The company’s growth estimates for the ongoing quarter and the next is 17.7% and 8.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 257.07%.

Volatility

Mettler’s last day, last week, and last month’s current intraday variation average was 6.38%, 4.43%, and 1.96%, respectively.

Mettler’s highest amplitude of average volatility was 7.76% (day), 4.72% (last week), and 3.54% (last month), respectively.

Mettler’s Stock Yearly Top and Bottom Value

Mettler’s stock is valued at $1,430.41 at 00:22 EST, way under its 52-week high of $1,626.62 and way higher than its 52-week low of $1,033.40.

Mettler’s Moving Average

Mettler’s worth is below its 50-day moving average of $1,448.75 and higher than its 200-day moving average of $1,424.72.

LEAVE A REPLY

Please enter your comment!
Please enter your name here